Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) Basic Net EPS Stands At $-1.19

0

Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) had an annual basic consolidated EPS of $-1.1852 for the period ended 2015-12-31. For the quarter ended 2015-12-31 which was on quarterly basis, the basic consolidated EPS reading was $-1.1852.

EPS from continuing operations

Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) reported $-1.1852 as the basic EPS from continuing operations for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations stood at $-1.1852 for the three-month period ended 2015-12-31.

EPS contribution from parent

From its parent company, Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) received basic EPS of $-1.1852 for the annual period ended 2015-12-31. EPS contribution from the parent company was $-1.1852 which was on quarterly basis for the period ended 2015-12-31.

Basic net EPS

A basic net EPS of $-1.19 was reported by Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) for the annual period ended 2015-12-31. For the three-month period ended 2015-12-31 which was on a quarterly basis, the company’s basic net EPS stood at $-1.19.

Consolidated diluted EPS

For the period ended 2015-12-31, $-1.1852 was reported as the annual consolidated diluted EPS reading. Consolidated diluted EPS was $-1.1852 for the quarter ended 2015-12-31.

Basic diluted EPS

Diluted EPS reading from continuing operation was $-1.1852 which was on annual basis but for the period ended 2015-12-31. From continuing operations, Diluted EPS was $-1.1852 for the quarter ended 2015-12-31.

Net diluted EPS

Net diluted EPS reading was $-1.19 for the annual period ended 2015-12-31 while the net diluted EPS for the quarterly period ended 2015-12-31 stood at $-1.19.

Diluted EPS from parent

Diluted EPS of $-1.1852 was received by Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) from its parent company which was for the annual period ended 2015-12-31. For the quarter ended 2015-12-31, diluted EPS contribution from the parent was $-1.1852 on quarterly basis. For the annual period ended 2015-12-31, $-1.19 was posted by Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) as net basic EPS reading.

For the quarter ended 2015-12-31, basic net EPS of $-1.19 was reported. The period ended 2015-12-31 had annual average basic shares outstanding of 103.898. But it was 103.898 for the quarter ended 2015-12-31. 103.898 and 103.898 were the diluted shares outstanding for the fiscal year ended is 2015-12-31 respectively.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 75 times, 1 visits today)